July 25, 2017
AkzoNobel today convenes an Extraordinary General Meeting of Shareholders (EGM) of Akzo Nobel N.V. to be held at Hilton Hotel, Apollolaan 138, 1077 BG Amsterdam, the Netherlands, on Friday, September 8, 2017 starting at 14.00 CET.
The agenda items are as follows:
- Appointment of Mr. T.F.J. Vanlancker as member of the Board of Management (voting point)
- Further explanation and discussion regarding AkzoNobel's response to the unsolicited and non-binding proposals made by PPG in March/April 2017 (discussion point)
In addition to the EGM, AkzoNobel also announces a range of measures designed to strengthen and maintain a constructive dialogue with its shareholders, including:
- The creation of a Supervisory Board committee for shareholder relations
- David Mayhew and team from JP Morgan Cazenove appointed as advisor for shareholder relations
- Senior Executive remuneration to be aligned to the new financial plan
- Program of meetings to introduce new CEO
- Augmented schedule of roadshows and conferences
- Enlarged program of analyst and investor webcasts and events
Antony Burgmans, Chairman of the Supervisory Board, commented:
"AkzoNobel values its relationship with shareholders and takes its responsibility towards them very seriously. In recent months this relationship, with a particular group of shareholders, has been impacted by events surrounding the Company.
"We have actively reached out to our shareholders to create a plan to strengthen our relationship. This has included feedback from 285 meetings and calls with over 200 investors that have been held in the past six months and a shareholder survey conducted in June of investors holding more than 42% of the total shareholding.
"As part of our enhanced shareholder relations plan we will host an EGM on 8 September. In addition to this, we have appointed David Mayhew and team from JP Morgan Cazenove as a special advisor to a newly established Supervisory Board committee on shareholder relations. We will increase our program of webcasts and events for analysts and investors, which will augment our ongoing schedule of roadshows and management meetings. Senior Executive remuneration will be aligned to the new financial plan.
"I am also able to confirm today that, barring any exceptional circumstances, I intend to retire as planned and in-line with the Dutch corporate governance code, from my position as Chairman of the Supervisory Board of AkzoNobel, following the completion of my third term in office in April 2018. A process is now underway to identify my successor.
"All our stakeholders are important and the Supervisory Board and the management team look forward to continued engagement with shareholders as we deliver on our strategy to accelerate growth and value creation."
For more information on the EGM and the agenda items, we refer to the Agenda with explanatory notes and the EGM Notice. AkzoNobel will also update on the timing of shareholder approval for the separation of Specialty Chemicals. These documents can be found on the AkzoNobel corporate website (www.akzonobel.com).
- - -
About AkzoNobel
AkzoNobel creates everyday essentials to make people's lives more liveable and inspiring. As a leading global paints and coatings company and a major producer of specialty chemicals, we supply essential ingredients, essential protection and essential color to industries and consumers worldwide. Backed by a pioneering heritage, our innovative products and sustainable technologies are designed to meet the growing demands of our fast-changing planet, while making life easier. Headquartered in Amsterdam, the Netherlands, we have approximately 46,000 people in around 80 countries, while our portfolio includes well-known brands such as Dulux, Sikkens, International, Interpon and Eka. Consistently ranked as a leader in sustainability, we are dedicated to energizing cities and communities while creating a protected, colorful world where life is improved by what we do.
Not for publication - for more information
| AkzoNobel Media Relations | AkzoNobel Investor Relations |
| T: +31 (0)88 969 7833 | T +31 (0)88 969 7590 |
| Contact: Diana Abrahams | Contact: Lloyd Midwinter |
Safe Harbor Statement
This press release contains statements which address key issues such as AkzoNobel's growth strategy, future financial results, market positions, product development, products in the pipeline and product approvals. Such statements should be carefully considered, and it should be understood that many factors could cause forecasted and actual results to differ from these statements. These factors include, but are not limited to, price fluctuations, currency fluctuations, developments in raw material and personnel costs, pensions, physical and environmental risks, legal issues, and legislative, fiscal, and other regulatory measures. Stated competitive positions are based on management estimates supported by information provided by specialized external agencies. For a more comprehensive discussion of the risk factors affecting our business please see our latest annual report, a copy of which can be found on our website: www.akzonobel.com.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/4eaa0da1-b557-47eb-bda6-789683962e3d


Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Apple Turns 50: From Garage Startup to AI Crossroads
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Britain Courts Anthropic Amid US Defense Department Dispute
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



